Literature DB >> 9830189

What happens when doctors stop prescribing temazepam? Use of alternative therapies.

T C Gilhooly1, M G Webster, N W Poole, S Ross.   

Abstract

We investigated the withdrawal of temazepam in a single general practice using two alternative prescribing policies: an alternative benzodiazepine; or an alternative group of drugs recommended for short-term management of insomnia, including sedative antihistamines and chloral hydrate. The study showed that temazepam prescribing in general practice can be reduced or stopped by using a simple intervention. An alternative benzodiazepine is useful in helping patients to stop their use of hypnotic agents. The use of antihistamines as substitute hypnotics is not advocated on the basis of our findings.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9830189      PMCID: PMC1313227     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  5 in total

1.  The dual use of opioids and temazepam by drug injectors in Glasgow (Scotland).

Authors:  A J Forsyth; D Farquhar; M Gemmell; D Shewan; J B Davies
Journal:  Drug Alcohol Depend       Date:  1993-05       Impact factor: 4.492

2.  Reducing the use of benzodiazepines in general practice.

Authors:  J W Tiller
Journal:  BMJ       Date:  1994-07-02

3.  Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice.

Authors:  M A Cormack; K G Sweeney; H Hughes-Jones; G A Foot
Journal:  Br J Gen Pract       Date:  1994-01       Impact factor: 5.386

4.  Audit and follow-up of chronic benzodiazepine tranquillizer use in one general practice.

Authors:  J M Morrison
Journal:  Fam Pract       Date:  1990-12       Impact factor: 2.267

5.  Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines.

Authors:  K Bashir; M King; M Ashworth
Journal:  Br J Gen Pract       Date:  1994-09       Impact factor: 5.386

  5 in total
  2 in total

Review 1.  Withdrawing benzodiazepines in primary care.

Authors:  Malcolm Lader; Andre Tylee; John Donoghue
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 2.  Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review.

Authors:  André S Pollmann; Andrea L Murphy; Joel C Bergman; David M Gardner
Journal:  BMC Pharmacol Toxicol       Date:  2015-07-04       Impact factor: 2.483

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.